Chinese medicament for treating asthma

Abstract

The invention provides a Chinese medicament for treating asthma. The Chinese medicament consists of fifteen medicaments including ginkgo seeds, ephedra, common coltsfoot flowers, pinellia tuber, tangerine peel, white mulberry roots-barks, poria, largehead atractylodes rhizome, perillaseed, baical skullcap roots, apricot kernels, astragalus, radix glycyrrhizae preparata, jujubes and tokays. A preparation method comprises the following steps of weighing the tokays in parts by weights, and grinding the tokays into powder; weighing the other fourteen medicaments in parts by weights, adding cold water in a way that a water level is higher than a medicament level, impregnating the medicaments for 0.5 to 1 hour, boiling a mixture with high flame, decocting the mixture for 20 to 30 minutes with low flame, and filtering the mixture to remove dregs to obtain liquid medicine; performing decoction twice, mixing the liquid medicine obtained by twice decoction, boiling the mixed liquid medicine, and decocting the mixed liquid medicine for 3 to 5 minutes. The Chinese medicament has the effects of relieving cough and asthma, reducing phlegm, reinforcing qi, clearing heat, removing toxicity, nourishing blood and promoting blood circulation to remove blood stasis, has good effects, and can quickly take effect, and the toxicity and the adverse effects of the medicament can also be reduced, so that the aim of comprehensively recovering various physiological functions of tracheas and lung tissues is fulfilled.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating asthma. Background technique [0002] Asthma is a respiratory disease characterized by airway hyperresponsiveness. The common symptoms of asthma patients are symptoms such as paroxysmal wheezing, shortness of breath, chest tightness or cough, and a small number of patients may also have chest pain as the main manifestation. The pathogenesis of asthma is mainly due to internal resistance of phlegm, unfavorable lung qi, and chronic asthma, which often leads to deficiency of kidney yang, water flooding into phlegm, or yin deficiency and fire rising, burning liquid into phlegm. A severe acute attack in a patient with asthma can be fatal if not treated in time. Poorly controlled asthma patients will affect their daily work and daily life, which can lead to missed work and school, limited activities and sports, reduced quality o...

AI Technical Summary

Problems solved by technology

[0004] The object of the present invention is to provide a kind of traditional Chinese medicine for the treatment of asthma, to overcome the shortcomings of the medicines for the treatment of asthma in the prior art, such as treating the symptoms but not the root cause, large toxic and side effects, high cost and unsatisfactory effect